CLB - NYSE
Core Laboratories N.V.
$13.69
+0.66%Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
At a Glance
Live SnapshotCore Laboratories N.V. Management Team
Lawrence V. Bruno
Chairman of the Board, Chief Executive Officer, President & Chief Operating Officer
Compensation
$1,475,386
Billy Anthony
President of Owen Oil Tools
Christopher Scott Hill
Senior Vice President & Chief Financial Officer
Compensation
$668,923
Gwendolyn Y. Gresham
Senior Vice President of Corporate Development & Investor Relations
Compensation
$574,565
J. Donald Dumas Jr.
Senior Vice President of Production Enhancement & Business Development
Mark Damian Tattoli
Senior Vice President, Secretary & General Counsel
Compensation
$576,758
Leslie Linklater
Vice President of People, Organization & Culture
Sow Hang Teo
Vice President, Treasurer & Chief Accounting Officer
Core Laboratories N.V. Insider Positioning
During the last 12 months, there has been no insider trading activity reported for CLB.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
0
0.00
0
0.00
+0
+$0
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
No buying activity
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
No insider trading activity reported. This could indicate blackout periods, lack of conviction, or regulatory restrictions.
Insider Participation
No insider trading activity reported from any insiders in the past year.
SEC Filings
CLB - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A N/A | April 28, 2023 | April 28, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 22, 2022 | May 19, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 19, 2021 | May 19, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 20, 2020 | May 20, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 20, 2019 | May 23, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 23, 2018 | May 24, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 24, 2017 | May 18, 2017 | 2017 | |
DEF 14A DEF 14A 2016 N/A | March 23, 2016 | May 19, 2016 | 2016 | |
DEF 14A DEF 14A 2015 N/A | March 20, 2015 | May 21, 2015 | 2015 | |
DEF 14A DEF 14A 2014 N/A | March 19, 2014 | May 13, 2014 | 2014 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.